Lung and blood lymphocytes NTPDase and acetylcholinesterase activity in cigarette smoke-exposed rats treated with curcumin

Biomedicine and Preventive Nutrition

Volumn 1, Issue 2, 2011, Pages 109-115

  Jaques, Jeandre Augusto dos Santos ^a   Rezer, João Felipe Peres ^a   Ruchel, Jader Betsch ^a   Becker, Lara Vargas ^a   Saydelles da Rosa, Cíntia ^a   Souza, Viviane do Carmo Gonçalves ^a   Luz, Sônia Cristina Almeida da ^a   Gutierres, Jessié Martins ^a   Gonçalves, Jamile Fabbrin ^b   Morsch, Vera Maria ^a   Schetinger, Maria Rosa Chitolina ^a,b   Leal, Daniela Bitencourt Rosa ^a  

^a FEDERAL UNIVERSITY OF SANTA MARIA   (Brazil)

^b FEDERAL UNIVERSITY OF RIO GRANDE DO SUL   (Brazil)

Author keywords

Acetylcholinesterase; Curcumin; NTPDase

Indexed keywords

ACETYLCHOLINESTERASE; ADENOSINE DIPHOSPHATE; ADENOSINE TRIPHOSPHATE; CURCUMIN; HYDROLASE; NUCLEOSIDE TRIPHOSPHATE DIPHOSPHOHYDROLASE; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CELL SEPARATION; CIGARETTE SMOKING; CONTROLLED STUDY; DRUG MECHANISM; ENZYME ACTIVITY; HISTOPATHOLOGY; LUNG STRUCTURE; MALE; NONHUMAN; PERIPHERAL LYMPHOCYTE; PRIORITY JOURNAL; RAT;

EID: 83655191671     PISSN: 22105239     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.bionut.2011.02.003     Document Type: Article

References (57)

1. Kuper H., Adami H.O., Boffetta P. Tobacco use, cancer causation and public health impact. J Intern Med 2002, 251(6):455-466.
2. Stampfli M.R., Anderson G.P. How cigarette smoke skews immune responses to promote infection, lung disease and cancer. Nat Rev Immunol 2009, 9(5):377-384.
3. Barnes P.J. Alveolar macrophages as orchestrators of COPD. Copd 2004, 1(1):59-70.
4. Sopori M. Effects of cigarette smoke on the immune system. Nat Rev Immunol 2002, 2(5):372-377.
5. Grumelli S., Corry D.B., Song L.Z., Song L., Green L., Huh J., et al. An immune basis for lung parenchymal destruction in chronic obstructive pulmonary disease and emphysema. PLoS Med 2004, 1(1):e8.
6. Haq I., Chappell S., Johnson S.R., Lotya J., Daly L., Morgan K., et al. Association of MMP-2 polymorphisms with severe and very severe COPD: a case control study of MMPs-1, 9 and 12 in a European population. BMC Med Genet 2010, 11:7.
7. Maliszewski C.R., Delespesse G.J., Schoenborn M.A., Armitage R.J., Fanslow W.C., Nakajima T., et al. The CD39 lymphoid cell activation antigen. Molecular cloning and structural characterization. J Immunol 1994, 153(8):3574-3583.
8. Burch L.H., Picher M. E-NTPDases in human airways: regulation and relevance for chronic lung diseases. Purinergic Signal 2006, 2(2):399-408.
9. Dwyer K.M., Deaglio S., Gao W., Friedman D., Strom T.B., Robson S.C. CD39 and control of cellular immune responses. Purinergic Signal 2007, 3(1-2):171-180.
10. Schetinger M.R., Morsch V.M., Bonan C.D., Wyse A.T. NTPDase and 5'-nucleotidase activities in physiological and disease conditions: new perspectives for human health. Biofactors 2007, 31(2):77-98.
11. Battisti V., Schetinger M.R., Maders L.D., Santos K.F., Bagatini M.D., Correa M.C., et al. Changes in acetylcholinesterase (AchE) activity in lymphocytes and whole blood in acute lymphoblastic leukemia patients. Clin Chim Acta 2009, 402(1-2):114-118.
12. Pavlov V.A., Tracey K.J. The cholinergic anti-inflammatory pathway. Brain Behav Immun 2005, 19(6):493-499.
13. Dowdall M.J., Boyne A.F., Whittaker V.P. Adenosine triphosphate. A constituent of cholinergic synaptic vesicles. Biochem J 1974, 140(1):1-12.
14. Zimmermann H. ATP and acetylcholine, equal brethren. Neurochem Int 2008, 52(4-5):634-648.
15. Ilbey Y.O., Ozbek E., Cekmen M., Simsek A., Otunctemur A., Somay A. Protective effect of curcumin in cisplatin-induced oxidative injury in rat testis: mitogen-activated protein kinase and nuclear factor-kappa B signaling pathways. Hum Reprod 2009, 24(7):1717-1725.
16. Kamat C.D., Gadal S., Mhatre M., Williamson K.S., Pye Q.N., Hensley K. Antioxidants in central nervous system diseases: preclinical promise and translational challenges. J Alzheimers Dis 2008, 15(3):473-493.
17. Kowluru R.A., Kanwar M. Effects of curcumin on retinal oxidative stress and inflammation in diabetes. Nutr Metab (Lond) 2007, 4:8.
18. Reeta K.H., Mehla J., Gupta Y.K. Curcumin is protective against phenytoin-induced cognitive impairment and oxidative stress in rats. Brain Res 2009, 1301:52-60.
19. Tang H., Lu D., Pan R., Qin X., Xiong H., Dong J. Curcumin improves spatial memory impairment induced by human immunodeficiency virus type 1 glycoprotein 120 V3 loop peptide in rats. Life Sci 2009, 85(1-2):1-10.
20. De R., Kundu P., Swarnakar S., Ramamurthy T., Chowdhury A., Nair G.B., et al. Antimicrobial activity of curcumin against Helicobacter pylori isolates from India and during infections in mice. Antimicrob Agents Chemother 2009, 53(4):1592-1597.
21. Rao C.V., Rivenson A., Simi B., Reddy B.S. Chemoprevention of colon carcinogenesis by dietary curcumin, a naturally occurring plant phenolic compound. Cancer Res 1995, 55(2):259-266.
22. Pan C.J., Tang J.J., Shao Z.Y., Wang J., Huang N. Improved blood compatibility of rapamycin-eluting stent by incorporating curcumin. Colloids Surf B Biointerfaces 2007, 59(1):105-111.
23. Aggarwal B.B., Harikumar K.B. Potential therapeutic effects of curcumin, the anti-inflammatory agent, against neurodegenerative, cardiovascular, pulmonary, metabolic, autoimmune and neoplastic diseases. Int J Biochem Cell Biol 2009, 41(1):40-59.
24. Arun N., Nalini N. Efficacy of turmeric on blood sugar and polyol pathway in diabetic albino rats. Plant Foods Hum Nutr 2002, 57(1):41-52.
25. Deodhar S.D., Sethi R., Srimal R.C. Preliminary study on antirheumatic activity of curcumin (diferuloyl methane). Indian J Med Res 1980, 71:632-634.
26. Aggarwal B.B. Targeting inflammation-induced obesity and metabolic diseases by curcumin and other nutraceuticals. Annu Rev Nutr 2010, 30:173-199.
27. Koosirirat C., Linpisarn S., Changsom D., Chawansuntati K., Wipasa J. Investigation of the anti-inflammatory effect of Curcuma longa in Helicobacter pylori-infected patients. Int Immunopharmacol 2010, 10(7):815-818.
28. Wu S.J., Tam K.W., Tsai Y.H., Chang C.C., Chao J.C. Curcumin and saikosaponin a inhibit chemical-induced liver inflammation and fibrosis in rats. Am J Chin Med 2010, 38(1):99-111.
29. Thome G.R., Mazzanti C.M., Ahmed M., Correa M., Spanevello R.M., Maldonado P.A., et al. Activity of ectonucleotidases and adenosine deaminase in rats exposed to cigarette smoke. Inhal Toxicol 2009, 21(11):906-912.
30. Tolosa E.M.C., Rodrigues C.J. Manual de técnicas para histologia normal e patológica 2003, Manole, São Paulo.
31. Boyum A. Isolation of mononuclear cells and granulocytes from human blood. Isolation of monuclear cells by one centrifugation, and of granulocytes by combining centrifugation and sedimentation at 1g. Scand J Clin Lab Invest Suppl 1968, 97:77-89.
32. Jaques J.A., Peres Rezer J.F., Ruchel J.B., Gutierres J., Bairros A.V., Gomes Farias I.L., et al. A method for isolation of rat lymphocyte-rich mononuclear cells from lung tissue useful for determination of nucleoside triphosphate diphosphohydrolase activity. Anal Biochem 2011, 410(1):34-39.
33. Leal D.B., Streher C.A., Bertoncheli Cde M., Carli L.F., Leal C.A., da Silva J.E., et al. HIV infection is associated with increased NTPDase activity that correlates with CD39-positive lymphocytes. Biochim Biophys Acta 2005, 1746(2):129-134.
34. Chan K.M., Delfert D., Junger K.D. A direct colorimetric assay for Ca2+ -stimulated ATPase activity. Anal Biochem 1986, 157(2):375-380.
35. Ellman G.L., Courtney K.D., Andres V., Feather-Stone R.M. A new and rapid colorimetric determination of acetylcholinesterase activity. Biochem Pharmacol 1961, 7:88-95.
36. Fitzgerald B.B., Costa L.G. Modulation of muscarinic receptors and acetylcholinesterase activity in lymphocytes and in brain areas following repeated organophosphate exposure in rats. Fundam Appl Toxicol 1993, 20(2):210-216.
37. Bradford M.M. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem 1976, 72:248-254.
38. Suzuki M., Betsuyaku T., Ito Y., Nagai K., Odajima N., Moriyama C., et al. Curcumin attenuates elastase- and cigarette smoke-induced pulmonary emphysema in mice. Am J Physiol Lung Cell Mol Physiol 2009, 296(4):L614-L623.
39. Doz E., Noulin N., Boichot E., Guenon I., Fick L., Le Bert M., et al. Cigarette smoke-induced pulmonary inflammation is TLR4/MyD88 and IL-1R1/MyD88 signaling dependent. J Immunol 2008, 180(2):1169-1178.
40. Barnes P.J., Shapiro S.D., Pauwels R.A. Chronic obstructive pulmonary disease: molecular and cellular mechanisms. Eur Respir J 2003, 22(4):672-688.
41. Michaud S.E., Dussault S., Groleau J., Haddad P., Rivard A. Cigarette smoke exposure impairs VEGF-induced endothelial cell migration: role of NO and reactive oxygen species. J Mol Cell Cardiol 2006, 41(2):275-284.
42. Molet S., Belleguic C., Lena H., Germain N., Bertrand C.P., Shapiro S.D., et al. Increase in macrophage elastase (MMP-12) in lungs from patients with chronic obstructive pulmonary disease. Inflamm Res 2005, 54(1):31-36.
43. Beutler B., Jiang Z., Georgel P., Crozat K., Croker B., Rutschmann S., et al. Genetic analysis of host resistance: toll-like receptor signaling and immunity at large. Annu Rev Immunol 2006, 24:353-389.
44. Lee S.H., Goswami S., Grudo A., Song L.Z., Bandi V., Goodnight-White S., et al. Antielastin autoimmunity in tobacco smoking-induced emphysema. Nat Med 2007, 13(5):567-569.
45. Imai M., Goepfert C., Kaczmarek E., Robson S.C. CD39 modulates IL-1 release from activated endothelial cells. Biochem Biophys Res Commun 2000, 270(1):272-278.
46. la Sala A., Ferrari D., Di Virgilio F., Idzko M., Norgauer J., Girolomoni G. Alerting and tuning the immune response by extracellular nucleotides. J Leukoc Biol 2003, 73(3):339-343.
47. Benowitz N.L. Pharmacology of nicotine: addiction and therapeutics. Annu Rev Pharmacol Toxicol 1996, 36:597-613.
48. Kalpana C., Menon V.P. Curcumin ameliorates oxidative stress during nicotine-induced lung toxicity in Wistar rats. Ital J Biochem 2004, 53(2):82-86.
49. Punithavathi D., Venkatesan N., Babu M. Curcumin inhibition of bleomycin-induced pulmonary fibrosis in rats. Br J Pharmacol 2000, 131(2):169-172.
50. Punithavathi D., Venkatesan N., Babu M. Protective effects of curcumin against amiodarone-induced pulmonary fibrosis in rats. Br J Pharmacol 2003, 139(7):1342-1350.
51. Xu M., Deng B., Chow Y.L., Zhao Z.Z., Hu B. Effects of curcumin in treatment of experimental pulmonary fibrosis: a comparison with hydrocortisone. J Ethnopharmacol 2007, 112(2):292-299.
52. Shishodia S., Potdar P., Gairola C.G., Aggarwal B.B. Curcumin (diferuloylmethane) down-regulates cigarette smoke-induced NF-kappaB activation through inhibition of IkappaBalpha kinase in human lung epithelial cells: correlation with suppression of COX-2, MMP-9 and cyclin D1. Carcinogenesis 2003, 24(7):1269-1279.
53. Vanisree A.J., Sudha N. Curcumin combats against cigarette smoke and ethanol-induced lipid alterations in rat lung and liver. Mol Cell Biochem 2006, 288(1-2):115-123.
54. Kawashima K., Fujii T. The lymphocytic cholinergic system and its contribution to the regulation of immune activity. Life Sci 2003, 74(6):675-696.
55. Fujii T., Kawashima K. Ca2+ oscillation and c-fos gene expression induced via muscarinic acetylcholine receptor in human T- and B-cell lines. Naunyn Schmiedebergs Arch Pharmacol 2000, 362(1):14-21.
56. Fujii T., Kawashima K. Calcium signaling and c-Fos gene expression via M3 muscarinic acetylcholine receptors in human T- and B-cells. Jpn J Pharmacol 2000, 84(2):124-132.
57. Fujii T., Kawashima K. YM905, a novel M3 antagonist, inhibits Ca2+ signaling and c-fos gene expression mediated via muscarinic receptors in human T cells. Gen Pharmacol 2000, 35(2):71-75.